Sponsor Pipeline

Newave Pharmaceutical Inc Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
3
Recruiting
1
Phase 3
10
Disease Areas
Active Trials by Phase
Phase 3
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07342478 ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R… CLL / SLL Recruiting
Phase 1
NCT04775745 Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell… CLL/SLL Recruiting
NCT04771572 Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL… Non Hodgkin Lymphoma Recruiting
Disease Areas
Leukemia (3) Chronic Lymphocytic Leukemia (CLL) (3) Acute Myeloid Leukemia (AML) (1) Acute Lymphoblastic Leukemia (ALL) (1) Multiple Myeloma (1) Non-Hodgkin Lymphoma (1) Myelodysplastic Syndromes (MDS) (1) Myelofibrosis (1) Follicular Lymphoma (1) Mantle Cell Lymphoma (1)
Get alerts when Newave Pharmaceutical Inc's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free